A detailed history of First Financial Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, First Financial Corp holds 10,168 shares of ABBV stock, worth $2.04 Million. This represents 0.96% of its overall portfolio holdings.

Number of Shares
10,168
Previous 10,298 1.26%
Holding current value
$2.04 Million
Previous $1.77 Million 13.65%
% of portfolio
0.96%
Previous 0.91%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$163.84 - $199.33 $21,299 - $25,912
-130 Reduced 1.26%
10,168 $2.01 Million
Q2 2024

Jul 11, 2024

SELL
$154.79 - $180.76 $120,736 - $140,992
-780 Reduced 7.04%
10,298 $1.77 Million
Q1 2024

Apr 12, 2024

SELL
$159.82 - $182.1 $827,388 - $942,731
-5,177 Reduced 31.85%
11,078 $2.02 Million
Q4 2023

Jan 16, 2024

SELL
$137.6 - $154.97 $84,211 - $94,841
-612 Reduced 3.63%
16,255 $2.52 Million
Q3 2023

Oct 11, 2023

BUY
$133.59 - $154.65 $965,454 - $1.12 Million
7,227 Added 74.97%
16,867 $2.51 Million
Q2 2023

Jul 14, 2023

SELL
$132.51 - $164.9 $25,706 - $31,990
-194 Reduced 1.97%
9,640 $1.3 Million
Q1 2023

Apr 17, 2023

SELL
$144.61 - $166.54 $24,005 - $27,645
-166 Reduced 1.66%
9,834 $1.57 Million
Q4 2022

Jan 17, 2023

SELL
$138.31 - $165.87 $2,766 - $3,317
-20 Reduced 0.2%
10,000 $0
Q3 2022

Oct 20, 2022

SELL
$134.21 - $153.93 $9,260 - $10,621
-69 Reduced 0.68%
10,020 $1.35 Million
Q2 2022

Jul 15, 2022

SELL
$137.62 - $174.96 $5,367 - $6,823
-39 Reduced 0.39%
10,089 $1.55 Million
Q1 2022

Apr 14, 2022

SELL
$131.98 - $163.75 $17,817 - $22,106
-135 Reduced 1.32%
10,128 $1.64 Million
Q4 2021

Jan 14, 2022

BUY
$107.43 - $135.93 $5,478 - $6,932
51 Added 0.5%
10,263 $1.39 Million
Q3 2021

Oct 18, 2021

SELL
$106.4 - $120.78 $5,958 - $6,763
-56 Reduced 0.55%
10,212 $1.1 Million
Q2 2021

Jul 15, 2021

BUY
$105.21 - $117.21 $44,924 - $50,048
427 Added 4.34%
10,268 $1.16 Million
Q1 2021

Apr 15, 2021

BUY
$102.3 - $112.62 $7,877 - $8,671
77 Added 0.79%
9,841 $1.07 Million
Q4 2020

Jan 15, 2021

BUY
$80.49 - $108.67 $4,426 - $5,976
55 Added 0.57%
9,764 $1.05 Million
Q3 2020

Oct 13, 2020

SELL
$85.91 - $100.83 $2,577 - $3,024
-30 Reduced 0.31%
9,709 $850,000
Q2 2020

Jul 15, 2020

SELL
$73.37 - $98.18 $9,978 - $13,352
-136 Reduced 1.38%
9,739 $956,000
Q1 2020

Apr 15, 2020

SELL
$64.5 - $97.79 $16,254 - $24,643
-252 Reduced 2.49%
9,875 $752,000
Q3 2019

Oct 15, 2019

SELL
$62.98 - $75.72 $14,926 - $17,945
-237 Reduced 2.29%
10,127 $767,000
Q2 2019

Jul 15, 2019

SELL
$65.7 - $83.98 $10,052 - $12,848
-153 Reduced 1.45%
10,364 $754,000
Q1 2019

Apr 12, 2019

SELL
$77.14 - $90.79 $9,796 - $11,530
-127 Reduced 1.19%
10,517 $847,000
Q4 2018

Jan 15, 2019

SELL
$77.85 - $96.01 $23,043 - $28,418
-296 Reduced 2.71%
10,644 $981,000
Q3 2018

Oct 16, 2018

SELL
$88.91 - $98.84 $12,269 - $13,639
-138 Reduced 1.25%
10,940 $1.04 Million
Q2 2018

Jul 12, 2018

SELL
$89.78 - $106.23 $22,085 - $26,132
-246 Reduced 2.17%
11,078 $1.03 Million
Q1 2018

Apr 17, 2018

SELL
$92.01 - $123.21 $74,436 - $99,676
-809 Reduced 6.67%
11,324 $1.07 Million
Q4 2017

Jan 16, 2018

SELL
$89.56 - $98.21 $135,325 - $148,395
-1,511 Reduced 11.07%
12,133 $1.17 Million
Q3 2017

Oct 13, 2017

BUY
$69.85 - $89.22 $953,033 - $1.22 Million
13,644
13,644 $1.21 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $354B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track First Financial Corp Portfolio

Follow First Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Financial Corp , based on Form 13F filings with the SEC.

News

Stay updated on First Financial Corp with notifications on news.